ARCHIVES

ACS Cancer Control Research Grant Programs Available

This article is from The Cancer Letter archive.

Vol. 26 No. 18 | May 5, 2000

Download PDF Visit The Full Archive

Related Articles

In Brief: NCCN, ACS Write Prostate Cancer Guideline For Patient use; Gates gives $4.5M to UPCC

July 2, 1999

Fidaxomicin for CDI Therapy More Cost-Effective Than Vancomycin, Study Says

September 26, 2014

NCI CTEP: Approved Trials For The Month of October

October 28, 2011

O’Shaughnessy, Burris To Present for Genentech At FDA Hearing At June 28-29

June 10, 2011

Study Suggests Biomarker For Resistance to Tamoxifen

March 25, 2011

‘Rush To Downsize’ Is A Danger To NCI, Broder Warns In A Farewell Address

January 13, 1995